Nkarta appoints alyssa levin chief financial and business officer

South san francisco, calif., july 05, 2023 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced the appointment of alyssa levin as chief financial and business officer.
NKTX Ratings Summary
NKTX Quant Ranking